Skip to main content
Jafron Biomedical Co.,Ltd. logo

Jafron Biomedical Co.,Ltd. — Investor Relations & Filings

Ticker · 300529 ISIN · CNE100002995 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,842 across all filing types
Latest filing 2023-03-30 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300529

About Jafron Biomedical Co.,Ltd.

https://www.jafron.com

Jafron Biomedical Co.,Ltd. specializes in the research, development, and manufacturing of biomaterials and equipment for blood purification. The company is a primary provider of hemoperfusion technology, focusing on the production of adsorbent cartridges designed to remove specific toxins and inflammatory mediators from the bloodstream. Its core product portfolio includes the HA series of hemoperfusion cartridges, which are applied in clinical settings for end-stage renal disease, acute poisoning, critical care, and liver failure. Beyond consumables, the company develops blood purification machines and integrated treatment systems. These solutions target clinical applications in nephrology, intensive care, and hepatology. By leveraging advanced resin adsorption technology, the company provides specialized extracorporeal blood treatment options aimed at improving patient outcomes in complex medical conditions.

Recent filings

Filing Released Lang Actions
关于监事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of members to the company's supervisory board (监事会换届选举). It details the candidates, their qualifications, and the process for the election at the shareholders' meeting. There is no financial data, audit information, or report content. The document is about changes in the company's supervisory board members, which falls under management or board information announcements. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is short and it is not a report publication announcement or regulatory filing. Confidence is high due to clear content about board member changes.
2023-03-30 Chinese
公司奋斗者一号员工持股计划（草案）摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed draft summary of an employee stock ownership plan (员工持股计划) for 健帆生物科技集团股份有限公司. It includes comprehensive information about the plan's purpose, legal basis, participants, funding sources, stock sources, management structure, rights and obligations of holders, and governance procedures. The document is lengthy (15,000 characters) and contains substantive content about the employee stock ownership plan rather than just an announcement or a brief summary. It is not an annual report, earnings release, or a regulatory filing. It is not a proxy solicitation or voting results announcement. It is a detailed plan document related to capital structure and employee shareholding. According to the filing definitions, this type of document fits best under Capital/Financing Update (CAP), as it relates to company fundraising, financing activities, or capital structure changes through an employee stock ownership plan. Therefore, the classification is CAP with high confidence.
2023-03-30 Chinese
公司奋斗者一号员工持股计划（草案）
Capital/Financing Update Classification · 95% confidence The document is titled as a draft employee stock ownership plan (员工持股计划草案) for the company 健帆生物科技集团股份有限公司. It details the structure, purpose, funding, management, rights, and obligations related to an employee stock ownership plan. It includes specifics about share allocation, management committees, voting rights, lock-up periods, and legal compliance. This is a detailed plan document outlining the employee stock ownership scheme, not an announcement of voting results, not a proxy solicitation, nor a general regulatory filing. It is not a financial report or earnings release. The document is comprehensive and lengthy (15,000 characters), indicating it is the plan itself, not just an announcement or summary. Therefore, the best fitting category is Capital/Financing Update (CAP), as employee stock ownership plans relate to capital structure and financing activities of the company.
2023-03-30 Chinese
关于选举产生第五届监事会职工代表监事的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election of a new employee representative supervisor to the company's supervisory board. It includes details about the election process, the elected individual's background, and compliance with relevant laws and regulations. There is no financial data, no mention of annual or quarterly reports, no audit information, and no indication of a shareholder vote result announcement. The content focuses on board/management information, specifically about the supervisory board composition. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not a report publication announcement or a regulatory filing. Confidence is high due to clear content focus on management changes.
2023-03-30 Chinese
2022年度监事会工作报告
Management Reports Classification · 95% confidence The document is titled as the "2022年度监事会工作报告" which translates to "2022 Supervisory Board Work Report". It details the supervisory board's activities, meetings, opinions on the company's operations, financial status, internal controls, and plans for 2023. It includes detailed oversight and review of financial reports and company governance but is not itself a full annual report or audit report. The document is a formal report from the supervisory board summarizing their work and opinions for the year 2022. This fits best under the category of Management Reports (MDA), which includes management's detailed explanation of financial results, business trends, and outlook. The document is 4153 characters long, which is substantive and contains detailed content rather than a brief announcement or certification. Therefore, the classification is MDA with high confidence.
2023-03-30 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 48th meeting of the 4th Board of Directors of the company, including approval of the 2022 Annual Report, financial statements, audit report, remuneration plans, board nominations, and other governance matters. It references multiple reports and documents that are disclosed separately on the official disclosure website (cninfo.com.cn). The document itself is a formal board meeting resolution announcement, not the full annual report or audit report. It includes board nominations and management changes but is primarily focused on board meeting decisions and approvals. Therefore, the document best fits the category of Board/Management Information (MANG), as it announces board meeting resolutions including board member nominations and other management-related decisions. The document length (8732 characters) and content confirm it is not a brief announcement or a simple report publication notice, but a substantive board meeting resolution announcement.
2023-03-30 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.